Albendazole Sulfoxide Plasma Levels and Efficacy of Antiparasitic Treatment in Patients With Parenchymal Neurocysticercosis

BACKGROUND: The efficacy of albendazole therapy in patients with parenchymal neurocysticercosis (NCC) is suboptimal. Plasma levels of albendazole sulfoxide (ASOX), the active metabolite of albendazole, are highly variable among patients. We hypothesized that high ASOX plasma levels during albendazol...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Infect Dis
Main Authors: Arroyo, Gianfranco, Bustos, Javier A, Lescano, Andres G, Gonzales, Isidro, Saavedra, Herbert, Rodriguez, Silvia, Pretell, E Javier, Bonato, Pierina S, Lanchote, Vera L, Takayanagui, Osvaldo M, Horton, John, Gonzalez, Armando E, Gilman, Robert H, Garcia, Hector H
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2019
Assuntos:
Articles and Commentaries
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6853673/
https://ncbi.nlm.nih.gov/pubmed/30715265
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciz085
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados